Target intelligence / Profile preview

High mobility group box 1 pseudogene 20 (HMGB1P20)

Target: HMGB1P20
Molecular classification: Other (Pseudogene)

Overview

HMGB1P20 is a processed pseudogene, designated as such due to its high sequence similarity to the parental HMGB1 gene. It does not encode a functional protein, nor is it implicated in disease or drug interactions according to current databases and literature. Entries for HMGB1P20 can be found in genomic resources such as HGNC:39103 and NCBI Gene:100128227[5]. There is no evidence it should be considered a receptor, enzyme, transporter, or other druggable therapeutic target.

Other names: High mobility group box 1 pseudogene 20HMGB1P20

Beyond the preview

Go deeper on High mobility group box 1 pseudogene 20 (HMGB1P20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group box 1 pseudogene 20 (HMGB1P20).

Explore the full profile